OGOREK ANTHONY JOSEPH /NY/ /ADV
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 714364
WILLIAMSVILLE, NY
Position in REGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$82,672
+$3,942 QoQ
Shares Held
107
+4.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026OGOREK ANTHONY JOSEPH /NY/ /ADV holds $248,111 across 6 Biotechnology names. REGN ranks #1 (33.3% of the industry book) .
All Filings in REGN
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $82,672 | 107 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $78,730 | 102 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $59,038 | 105 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $48,825 | 93 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $62,154 | 98 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $53,424 | 75 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $105,124 | 100 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $105,103 | 100 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $96,249 | 100 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $87,829 | 100 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $82,296 | 100 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $71,854 | 100 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $82,167 | 100 | Shares | Sole | 2023-05-03 | |
| No filing history on record for this holder in this stock. | ||||||